title: Who benefits from statins? Patient or focal plaque?
authors.forename: Kenichi
authors.initials: K
authors.lastname: Fujii
authors.forename: Tohru
authors.initials: T
authors.lastname: Masuyama
mesh_terms: D054058:Acute Coronary Syndrome / Q000628:therapy*; D000069059:Atorvastatin; D003324:Coronary Artery Disease / Q000628:therapy*; D003331:Coronary Vessels / Q000187:drug effects*; D005260:Female; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology*; D062645:Percutaneous Coronary Intervention; D058226:Plaque, Atherosclerotic; D011758:Pyrroles / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use*
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D011804:Quinolines; D000069059:Atorvastatin; C108475:pitavastatin